InvestorsHub Logo
Followers 34
Posts 5361
Boards Moderated 0
Alias Born 10/05/2021

Re: Bright Boy post# 564165

Wednesday, 02/01/2023 6:34:52 PM

Wednesday, February 01, 2023 6:34:52 PM

Post# of 720543
BB, thanks for everything! If they don't mention or signal DcVaxL or personalized cancer vaccine in their combo therapy tomorrow morning, Merck is simply hard balling, imo. While Keytruda ended in failure in Prostate, Colon, and GBM cancers etc as monotherapy, and while their combo partner Moderna expects phase 3 results in 5 yrs, hope they mention us tomorrow. It will take us $2+ easily. GBM is the toughest nut to crack among all cancers and DcVaxL did; LL showed the world the combo DcVaxL+Keytruda doing wonders in GBM beyond imagination.

Nothing is proven yet in their combo with the MRNA platform though.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News